Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
Open Access
- 26 March 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (15), 2114-2120
- https://doi.org/10.1016/j.vaccine.2009.01.125
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Influenza vaccination of recommended adult populations, U.S., 1989–2005Vaccine, 2008
- Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experienceExpert Review of Vaccines, 2008
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineThe New England Journal of Medicine, 2006
- Comparing data mining methods on the VAERS databasePharmacoepidemiology and Drug Safety, 2005
- The Role of the Vaccine Adverse Event Reporting System (VAERS) in Monitoring Vaccine SafetyPediatric Annals, 2004
- Understanding vaccine safety information from the Vaccine Adverse Event Reporting SystemThe Pediatric Infectious Disease Journal, 2004
- Risk of Anaphylaxis After Vaccination of Children and AdolescentsPEDIATRICS, 2003
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of Internal Medicine, 1998
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994
- GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771American Journal of Epidemiology, 1979